Price movement over the last 24 hours
Align Technology, Inc. vs ProShares Ultra Semiconductors — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while ProShares Ultra Semiconductors trades at $93.06. Which is the better fit depends on your goals.
| ALGN | USD | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $207.19 | $113.53 |
52-Week Low | $124.88 | $38.89 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
USD stock trades at $96.96, up 3.09% today, but technical indicators show a bearish bias with mixed signals. The stock faces resistance near $99 and support at $92. Recent news highlights include earnings reports from various companies, though specific financials for USD are not detailed in the provided data. The overall market sentiment is cautious, with oscillators neutral and moving averages slightly bullish.
The outlook for USD is clouded by bearish technicals and limited fundamental data. Investment opportunities may arise if the stock breaks above resistance, but risks include market volatility and lack of recent earnings visibility. Investors should await clearer financial updates to assess valuation and growth prospects.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →